Daniel Sutton - Concepedia

Author

Daniel Sutton

AstraZeneca (United Kingdom)ORCID

Also Known As

D Sutton, Daniel M Sutton, Daniel Sutton, Liqun Dong, Sutton, Daniel

Publications

436

Citations

H-Index

Concepts

All Affiliations

AstraZeneca (United Kingdom)AstraZeneca (Singapore)University of Glasgow AstraZeneca (Germany)Institute of Infection and Immunity

About

Daniel Sutton is an author at AstraZeneca (United Kingdom) specializing in medicine, molecular imaging, and tumor microenvironment.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	166
2	Engineering	3	3	107
3	Health Sciences	1	1	20
4	Biomedical Engineering	1	1	20
5	Biostatistics	1	1	49

Daniel Sutton

Publications

307

Citations

H-Index

Page 1

	Year	Citations
Treatment with Anti–Gremlin 1 Antibody Ameliorates Chronic Hypoxia/SU5416–Induced Pulmonary Arterial Hypertension in Mice Loredana Ciuclan, Kelly-Ann Sheppard, Liqun Dong, American Journal Of Pathology InflammationHypertensionPulmonary Arterial HypertensionPulmonary CirculationLung Inflammation	2013	64
The Next-Generation Oral Selective Estrogen Receptor Degrader Camizestrant (AZD9833) Suppresses ER+ Breast Cancer Growth and Overcomes Endocrine and CDK4/6 Inhibitor Resistance Mandy Lawson, Natalie Cureton, Susana R�os, Cancer Research	2023	54
Deep Learning-Based Annotation Transfer between Molecular Imaging Modalities: An Automated Workflow for Multimodal Data Integration Alan Race, Daniel Sutton, Grégory Hamm, Analytical Chemistry EngineeringMachine LearningMicroscopyAutomated WorkflowDigital Pathology	2021	49
The ATR inhibitor ceralasertib potentiates cancer checkpoint immunotherapy by regulating the tumor microenvironment Elizabeth Hardaker, Emilio Sanseviero, Ankur Karmokar, Nature Communications	2024	43
Method To Visualize the Intratumor Distribution and Impact of Gemcitabine in Pancreatic Ductal Adenocarcinoma by Multimodal Imaging Nicole Strittmatter, Frances M. Richards, Alan Race, Analytical Chemistry EngineeringOncologic ImagingMultimodalityTumor BiologyPancreatic Cancer	2022	38
Multi-modal molecular imaging maps the correlation between tumor microenvironments and nanomedicine distribution Nicole Strittmatter, Jennifer Moss, Alan Race, Theranostics NanoparticlesEngineeringOncologic ImagingBiomedical EngineeringNanomedicine	2022	20
Combining the AKT inhibitor capivasertib and SERD fulvestrant is effective in palbociclib-resistant ER+ breast cancer preclinical models Lorna Hopcroft, Eleanor M. Wigmore, Stuart C. Williamson, npj Breast Cancer Breast OncologyAkt Inhibitor CapivasertibPharmacotherapySelective Akt InhibitorTumor Biology	2023	15
Assessment of AAV9 distribution and transduction in rats after administration through Intrastriatal, Intracisterna magna and Lumbar Intrathecal routes Jayanth Chandran, Ekram Ahmed Chowdhury, Michael S. Perkinton, Gene Therapy	2022	14
Abstract 5737: Evaluation of the relationship between target expression and <i>in vivo</i> anti-tumor efficacy of AZD9592, an EGFR/c-MET targeted bispecific antibody drug conjugate Lara McGrath, Ying Zheng, Simon Christ, Cancer Research	2023	10

Page 1